JCR Pharmaceuticals Co., Ltd. (JP:4552) has released an update.
JCR Pharmaceuticals Co., Ltd. reports a significant decrease in net sales and profits for the first quarter of FY2024, with net sales dropping by 24.6% and profit attributable to owners declining by 87.5% compared to the same period last year. Despite this, the company maintains its dividend forecast and has not revised its financial results forecast for the fiscal year ending March 2025. No changes were reported in significant subsidiaries, accounting practices, or share numbers in the given period.
For further insights into JP:4552 stock, check out TipRanks’ Stock Analysis page.
